Form 4: Orthofix Medical Inc. CAO Acquires Shares and Stock Options

Geoffrey C. Gillespie, CAO of Orthofix Medical Inc., reports acquisition of common stock and stock options.

Summary

• On March 15, 2024, Geoffrey C. Gillespie, CAO of Orthofix Medical Inc., acquired 3,639 shares of common stock at a price of $13.74 per share.
• Gillespie also acquired 8,381 employee stock options with an exercise price of $13.74.
• Following these transactions, Gillespie beneficially owns 40,842 shares of common stock and 8,381 derivative securities.
• The restricted stock units vest in three equal installments on the first, second, and third anniversaries of the grant date.
• The options vest in installments over three years.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider transactions, which carries a neutral sentiment.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives regarding their holdings of company stock and options.

Comparison to Industry Standards

• Insider transactions are a normal part of corporate governance and are regularly disclosed by executives at publicly traded companies like Orthofix.
• The vesting schedules for the restricted stock units and stock options are typical for executive compensation packages, often designed to align executive interests with long-term company performance.
• Comparable companies such as Medtronic, Stryker, and Zimmer Biomet also have similar insider transaction reporting requirements and executive compensation structures.

Stakeholder Impact

• The transaction may have a minor positive impact on shareholder confidence as it indicates that a key executive is increasing their investment in the company.

Key Dates